![Ole Henrik André Brekke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ole Henrik André Brekke is a professional who has held several positions in different firms.
He was the Chief Executive Officer at Nykode Therapeutics ASA and Nextera AS, where he worked from 2009 to 2013.
He was also a Director of Research and Development at Affitech A, a Senior Scientist at the University of Oslo, a Senior Project Manager at Birkeland Innovasjon AS, and a Vice President of Immunology at Bio Medisinsk Innovasjon AS.
Additionally, he was a Manager of Research and Development at Invitrogen Dynal AS.
Dr. Brekke graduated and earned his doctorate from the University of Oslo.
| Sociétés | Poste | Fin |
|---|---|---|
Bio Medisinsk Innovasjon AS
 Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Engages in the development of biotechnology, bio-medical and pharmaceutical businesses | Corporate Officer/Principal | - |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Invitrogen Dynal AS | Directeur Technique/Scientifique/R&D | - |
Birkeland Innovasjon AS
 Birkeland Innovasjon AS Investment ManagersFinance Birkeland invests in academic R&D projects which have potential towards commercialization or consultancy services. They manage intellectual property rights on behalf of the University, out-licensing technology and facilitating the creation of knowledge-based startups. The firm's portfolio covers sectors such as biotechnology, food technology, medicine, ICT, chemistry, new materials, nanotechnology, energy, environmental technology and creative industries. Birkeland also administers a grant program intended to stimulate knowledge-based innovation within the University of Oslo. The program provides very-early-stage funding to allow researchers to establish first proof of concept. | Corporate Officer/Principal | - |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 7 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Birkeland Innovasjon AS
Birkeland Innovasjon AS Investment ManagersFinance Birkeland invests in academic R&D projects which have potential towards commercialization or consultancy services. They manage intellectual property rights on behalf of the University, out-licensing technology and facilitating the creation of knowledge-based startups. The firm's portfolio covers sectors such as biotechnology, food technology, medicine, ICT, chemistry, new materials, nanotechnology, energy, environmental technology and creative industries. Birkeland also administers a grant program intended to stimulate knowledge-based innovation within the University of Oslo. The program provides very-early-stage funding to allow researchers to establish first proof of concept. | Finance |
Bio Medisinsk Innovasjon AS
Bio Medisinsk Innovasjon AS BiotechnologyHealth Technology Engages in the development of biotechnology, bio-medical and pharmaceutical businesses | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer | Commercial Services |
Invitrogen Dynal AS |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
